PTK2 and melanoma: 4-hydroxycoumarin (4-HC) treatment (500 μM) caused a decrease in β-paxillin protein and mRNA levels, a decrease in FAK phosphorylation, the inhibition of the capacity to originate pulmonary metastases and the downregulation of Adhesion Regulating Molecule-1 (ARM-1) in melanoma cells [193].